Cerner plays a significant role in HOPS by collecting and managing the study data, ensuring quality assurance, conducting analysis and providing clinical and research expertise. Study personnel at the clinic sites and data managers in Cerner's coordinating center use Discovere ®, Cerner's Web-based research platform, to streamline their research activities. Kathy Wood, Cerner's research project leader for the study, is a co-author on many of the HOPS publications.
In recognizing this HOPS 20th Anniversary milestone, CDC, Cerner, site investigators, and research consultants underscore how research benefits clinicians, patients and their loved ones by providing insights to improve health and care.
Cerner is contributing to the systemic change of health and care delivery. For more than 30 years Cerner has been executing its vision to make health care safer and more efficient. We started with the foundation of digitizing paper processes and now offer the most comprehensive array of information software, professional services, medical device integration, remote hosting and employer health and wellness services. Cerner systems are used by everyone from individual consumers, to single-doctor practices, hospitals, employers and entire countries. Taking what we've learned over more than three decades, Cerner is building on the knowledge that is in the system to support evidence-based clinical decisions, prevent medical errors and empower patients in their care.Cerner® solutions are licensed by approximately 10,000 facilities around the world, including more than 2,700 hospitals; 4,150 physician practices; 45,000 physicians; 550 ambulatory facilities, such as laboratories, ambulatory centers, behavioral health centers, cardiac facilities, radiology clinics and surgery centers; 800 home health facilities; 45 employer sites and 1,750 retail pharmacies. Certain trademarks, service marks and logos (collectively, the "Marks") set forth herein are owned by Cerner Corporation and/or its subsidiaries in the United States and certain other countries throughout the world. All other non-Cerner Marks are the property of their respective owners. Nasdaq: CERN. For more information about Cerner, please visit www.cerner.com , Twitter , Facebook and YouTube .
CONTACT: Media Contact: Megan Moriarty, (816) 888-2470 email@example.com Investors Contact: Allan Kells, (816) 201-2445 firstname.lastname@example.org
Check Out Our Best Services for Investors
- $2.5+ million portfolio
- Large-cap and dividend focus
- Intraday trade alerts from Cramer
Access the tool that DOMINATES the Russell 2000 and the S&P 500.
- Buy, hold, or sell recommendations for over 4,300 stocks
- Unlimited research reports on your favorite stocks
- A custom stock screener
- Model portfolio
- Stocks trading below $10
- Intraday trade alerts